Skip to main content
Erschienen in: Inflammation 1/2013

01.02.2013

Serum Levels of IL-6, IL-10, IL-12, IL-17 and IFN-γ and Their Association with Markers of Bone Metabolism in Vitamin D-Deficient Female Students

verfasst von: Zahra Jamali, Mohammad Kazemi Arababadi, Gholamreza Asadikaram

Erschienen in: Inflammation | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Different studies have shown the regulatory effects of vitamin D3 on the immune system and bone metabolism. Regarding the effects of vitamin D on immune cells and the importance of cytokines on bone metabolism, we assessed the association between serum levels of interleukin (IL)-6, IL-10, IL-12, IL-17 and IFN-γ cytokines and bone metabolism markers (Ca, P, PTH, ALP) in female students with vitamin D deficiency compared with control group. A total of 100 subjects with 25-hydroxy vitamin D3 (25-(OH) D3) deficiency were selected as case and 100 subjects with sufficient 25-hydroxy vitamin D3 (25-(OH) D3) were selected as the control group. The serum levels of IL-6, IL-10, IL-12, IL-17 and IFN-γ were measured by ELISA method. Ionized Ca, PTH, P, ALP levels were also determined in all participants. The results showed a statistically significant positive correlation between the levels of ALP with IFN-γ, PTH with IL-17 and a significant negative correlation between P with IL-10 in vitamin D deficient group. The results suggest that IL-17, IFN-γ and IL-10 are important mediators of bone metabolism and vitamin D affect bone metabolism, at least in part, through immune system. In addition, not only vitamin D affect bone metabolism but also modulates immune responses.
Literatur
1.
Zurück zum Zitat Gordon, C.M., K.C. DePeter, H.A. Feldman, et al. 2004. Prevalence of vitamin D deficiency among healthy adolescents. Archives of Pediatrics & Adolescent Medicine 158: 531–537.CrossRef Gordon, C.M., K.C. DePeter, H.A. Feldman, et al. 2004. Prevalence of vitamin D deficiency among healthy adolescents. Archives of Pediatrics & Adolescent Medicine 158: 531–537.CrossRef
2.
Zurück zum Zitat Holick, M.F. 2004. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. American Journal of Clinical Nutrition 80: 1678S–1688S.PubMed Holick, M.F. 2004. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. American Journal of Clinical Nutrition 80: 1678S–1688S.PubMed
3.
Zurück zum Zitat Holick, M.F. 2004. Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. American Journal of Clinical Nutrition 79: 362–371.PubMed Holick, M.F. 2004. Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. American Journal of Clinical Nutrition 79: 362–371.PubMed
4.
Zurück zum Zitat Arababadi, M.K., M. Reza Mirzaei, S.M. Ali Sajadi, et al. 2012. Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: A study of patients from the southeast region of Iran. Inflammation 35: 797–802.PubMedCrossRef Arababadi, M.K., M. Reza Mirzaei, S.M. Ali Sajadi, et al. 2012. Interleukin (IL)-10 gene polymorphisms are associated with type 2 diabetes with and without nephropathy: A study of patients from the southeast region of Iran. Inflammation 35: 797–802.PubMedCrossRef
5.
Zurück zum Zitat Mak, G., and N.A. Hanania. 2011. Vitamin D and asthma. Current Opinion in Pulmonary Medicine 17: 1–5.PubMedCrossRef Mak, G., and N.A. Hanania. 2011. Vitamin D and asthma. Current Opinion in Pulmonary Medicine 17: 1–5.PubMedCrossRef
6.
Zurück zum Zitat Chang, J.H., H.R. Cha, D.S. Lee, et al. 2010. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 5: e12925.PubMedCrossRef Chang, J.H., H.R. Cha, D.S. Lee, et al. 2010. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 5: e12925.PubMedCrossRef
7.
Zurück zum Zitat Schwalfenberg, G.K. 2011. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Molecular Nutrition & Food Research 55: 96–108.CrossRef Schwalfenberg, G.K. 2011. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Molecular Nutrition & Food Research 55: 96–108.CrossRef
8.
Zurück zum Zitat Kazemi Arababadi, M. 2012. Interleukin-4 gene polymorphisms in type 2 diabetic patients with nephropathy. Iranian Journal of Kidney Diseases 4: 302–306. Kazemi Arababadi, M. 2012. Interleukin-4 gene polymorphisms in type 2 diabetic patients with nephropathy. Iranian Journal of Kidney Diseases 4: 302–306.
9.
Zurück zum Zitat Gozalbo, D., and M.L. Gil. 2009. IFN-gamma in Candida albicans infections. Frontiers in Bioscience 14: 1970–1978.PubMedCrossRef Gozalbo, D., and M.L. Gil. 2009. IFN-gamma in Candida albicans infections. Frontiers in Bioscience 14: 1970–1978.PubMedCrossRef
10.
Zurück zum Zitat Kurnatowski, P., and A.J. Kurnatowska. 2010. The immune response to fungal infections. Wiadomości Parazytologiczne 56: 23–27.PubMed Kurnatowski, P., and A.J. Kurnatowska. 2010. The immune response to fungal infections. Wiadomości Parazytologiczne 56: 23–27.PubMed
11.
Zurück zum Zitat Queiroz-Junior CM, Silva MJ, Correa JD, et al. 2010. A controversial role for IL-12 in immune response and bone resorption at apical periodontal sites. Clinical and Developmental Immunology 327417. Queiroz-Junior CM, Silva MJ, Correa JD, et al. 2010. A controversial role for IL-12 in immune response and bone resorption at apical periodontal sites. Clinical and Developmental Immunology 327417.
12.
Zurück zum Zitat Jilka, R.L., G. Hangoc, G. Girasole, et al. 1992. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257: 88–91.PubMedCrossRef Jilka, R.L., G. Hangoc, G. Girasole, et al. 1992. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257: 88–91.PubMedCrossRef
13.
Zurück zum Zitat Gaffen, S.L. 2004. Biology of recently discovered cytokines: Interleukin-17—a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Research & Therapy 6: 240–247.CrossRef Gaffen, S.L. 2004. Biology of recently discovered cytokines: Interleukin-17—a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Research & Therapy 6: 240–247.CrossRef
14.
Zurück zum Zitat Collin-Osdoby, P., L. Rothe, F. Anderson, et al. 2001. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. Journal of Biological Chemistry 276: 20659–20672.PubMedCrossRef Collin-Osdoby, P., L. Rothe, F. Anderson, et al. 2001. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. Journal of Biological Chemistry 276: 20659–20672.PubMedCrossRef
15.
Zurück zum Zitat Buckner JH. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nature Reviews Immunology 10: 849–859. Buckner JH. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nature Reviews Immunology 10: 849–859.
16.
Zurück zum Zitat Evans, K.E., and S.W. Fox. 2007. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biology 8: 4.PubMedCrossRef Evans, K.E., and S.W. Fox. 2007. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biology 8: 4.PubMedCrossRef
17.
Zurück zum Zitat El-Hajj Fuleihan, G., M. Nabulsi, H. Tamim, et al. 2006. Effect of vitamin D replacement on musculoskeletal parameters in school children: A randomized controlled trial. Journal of Clinical Endocrinology and Metabolism 91: 405–412.PubMedCrossRef El-Hajj Fuleihan, G., M. Nabulsi, H. Tamim, et al. 2006. Effect of vitamin D replacement on musculoskeletal parameters in school children: A randomized controlled trial. Journal of Clinical Endocrinology and Metabolism 91: 405–412.PubMedCrossRef
18.
Zurück zum Zitat Clarke, B. 2008. Normal bone anatomy and physiology. Clinical Journal of the American Society of Nephrology 3(Suppl 3): S131–S139.PubMedCrossRef Clarke, B. 2008. Normal bone anatomy and physiology. Clinical Journal of the American Society of Nephrology 3(Suppl 3): S131–S139.PubMedCrossRef
19.
Zurück zum Zitat Ershler, W.B., and E.T. Keller. 2000. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annual Review of Medicine 51: 245–270.PubMedCrossRef Ershler, W.B., and E.T. Keller. 2000. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annual Review of Medicine 51: 245–270.PubMedCrossRef
20.
Zurück zum Zitat Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine 340: 448–454.PubMedCrossRef Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine 340: 448–454.PubMedCrossRef
21.
Zurück zum Zitat Clowes, J.A., B.L. Riggs, and S. Khosla. 2005. The role of the immune system in the pathophysiology of osteoporosis. Immunology Reviews 208: 207–227.CrossRef Clowes, J.A., B.L. Riggs, and S. Khosla. 2005. The role of the immune system in the pathophysiology of osteoporosis. Immunology Reviews 208: 207–227.CrossRef
22.
Zurück zum Zitat Bendixen, A.C., N.K. Shevde, K.M. Dienger, et al. 2001. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proceedings of the National Academy of Sciences of the United States of America 98: 2443–2448.PubMedCrossRef Bendixen, A.C., N.K. Shevde, K.M. Dienger, et al. 2001. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proceedings of the National Academy of Sciences of the United States of America 98: 2443–2448.PubMedCrossRef
23.
Zurück zum Zitat Takeuchi, Y., S. Watanabe, G. Ishii, et al. 2002. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. Journal of Biological Chemistry 277: 49011–49018.PubMedCrossRef Takeuchi, Y., S. Watanabe, G. Ishii, et al. 2002. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. Journal of Biological Chemistry 277: 49011–49018.PubMedCrossRef
24.
Zurück zum Zitat Palmqvist, P., E. Persson, H.H. Conaway, et al. 2002. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. Journal of Immunology 169: 3353–3362. Palmqvist, P., E. Persson, H.H. Conaway, et al. 2002. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. Journal of Immunology 169: 3353–3362.
25.
Zurück zum Zitat Ding, C., V. Parameswaran, R. Udayan, et al. 2008. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: A longitudinal study. Journal of Clinical Endocrinology and Metabolism 93: 1952–1958.PubMedCrossRef Ding, C., V. Parameswaran, R. Udayan, et al. 2008. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: A longitudinal study. Journal of Clinical Endocrinology and Metabolism 93: 1952–1958.PubMedCrossRef
26.
Zurück zum Zitat Scheidt-Nave, C., H. Bismar, G. Leidig-Bruckner, et al. 2001. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. Journal of Clinical Endocrinology and Metabolism 86: 2032–2042.PubMedCrossRef Scheidt-Nave, C., H. Bismar, G. Leidig-Bruckner, et al. 2001. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. Journal of Clinical Endocrinology and Metabolism 86: 2032–2042.PubMedCrossRef
27.
Zurück zum Zitat McKane, W.R., S. Khosla, J.M. Peterson, et al. 1994. Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women. Journal of Bone and Mineral Research 9: 1313–1318.PubMedCrossRef McKane, W.R., S. Khosla, J.M. Peterson, et al. 1994. Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women. Journal of Bone and Mineral Research 9: 1313–1318.PubMedCrossRef
28.
Zurück zum Zitat Kania, D.M., N. Binkley, M. Checovich, et al. 1995. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. Journal of the American Geriatrics Society 43: 236–239.PubMed Kania, D.M., N. Binkley, M. Checovich, et al. 1995. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. Journal of the American Geriatrics Society 43: 236–239.PubMed
29.
Zurück zum Zitat Abrahamsen, B., V. Bonnevie-Nielsen, E.N. Ebbesen, et al. 2000. Cytokines and bone loss in a 5-year longitudinal study—hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study. Journal of Bone and Mineral Research 15: 1545–1554.PubMedCrossRef Abrahamsen, B., V. Bonnevie-Nielsen, E.N. Ebbesen, et al. 2000. Cytokines and bone loss in a 5-year longitudinal study—hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study. Journal of Bone and Mineral Research 15: 1545–1554.PubMedCrossRef
30.
Zurück zum Zitat Kuroki, T., M. Shingu, Y. Koshihara, et al. 1994. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells. British Journal of Rheumatology 33: 224–230.PubMedCrossRef Kuroki, T., M. Shingu, Y. Koshihara, et al. 1994. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells. British Journal of Rheumatology 33: 224–230.PubMedCrossRef
31.
Zurück zum Zitat Uitterlinden, A.G., Y. Fang, J.B. Van Meurs, et al. 2004. Genetics and biology of vitamin D receptor polymorphisms. Gene 338: 143–156.PubMedCrossRef Uitterlinden, A.G., Y. Fang, J.B. Van Meurs, et al. 2004. Genetics and biology of vitamin D receptor polymorphisms. Gene 338: 143–156.PubMedCrossRef
32.
Zurück zum Zitat Gao, Y., F. Grassi, M.R. Ryan, et al. 2007. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. The Journal of Clinical Investigation 117: 122–132.PubMedCrossRef Gao, Y., F. Grassi, M.R. Ryan, et al. 2007. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. The Journal of Clinical Investigation 117: 122–132.PubMedCrossRef
33.
Zurück zum Zitat Cantorna, M.T. 2010. Mechanisms underlying the effect of vitamin D on the immune system. Proceedings of the Nutrition Society 69: 286–289.PubMedCrossRef Cantorna, M.T. 2010. Mechanisms underlying the effect of vitamin D on the immune system. Proceedings of the Nutrition Society 69: 286–289.PubMedCrossRef
34.
Zurück zum Zitat Goswami, J., N. Hernandez-Santos, L.A. Zuniga, et al. 2009. A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. European Journal of Immunology 39: 2831–2839.PubMedCrossRef Goswami, J., N. Hernandez-Santos, L.A. Zuniga, et al. 2009. A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss. European Journal of Immunology 39: 2831–2839.PubMedCrossRef
35.
Zurück zum Zitat Johnson, R.B., N. Wood, and F.G. Serio. 2004. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. Journal of Periodontology 75: 37–43.PubMedCrossRef Johnson, R.B., N. Wood, and F.G. Serio. 2004. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. Journal of Periodontology 75: 37–43.PubMedCrossRef
36.
Zurück zum Zitat Van Bezooijen, R.L., H.C. Farih-Sips, S.E. Papapoulos, et al. 1999. Interleukin-17: A new bone acting cytokine in vitro. Journal of Bone and Mineral Research 14: 1513–1521.CrossRef Van Bezooijen, R.L., H.C. Farih-Sips, S.E. Papapoulos, et al. 1999. Interleukin-17: A new bone acting cytokine in vitro. Journal of Bone and Mineral Research 14: 1513–1521.CrossRef
37.
Zurück zum Zitat Chabaud, M., J.M. Durand, N. Buchs, et al. 1999. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis and Rheumatism 42: 963–970.PubMedCrossRef Chabaud, M., J.M. Durand, N. Buchs, et al. 1999. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis and Rheumatism 42: 963–970.PubMedCrossRef
Metadaten
Titel
Serum Levels of IL-6, IL-10, IL-12, IL-17 and IFN-γ and Their Association with Markers of Bone Metabolism in Vitamin D-Deficient Female Students
verfasst von
Zahra Jamali
Mohammad Kazemi Arababadi
Gholamreza Asadikaram
Publikationsdatum
01.02.2013
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9531-9

Weitere Artikel der Ausgabe 1/2013

Inflammation 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.